Related Experiment Video
Updated: Aug 15, 2026
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Use of the bayley infant neurodevelopmental screener with premature infants
Kivilcim Gücüyener1, Ebru Ergenekon, A Sebnem Soysal
1Departments of Pediatric Neurology, Medical Faculty, Gazi University, Besevler, Ankara, Turkey. kivilcim@gazi.edu.tr
Insights
The Bayley Infant Neurodevelopmental Screener (BINS) effectively identifies high-risk preterm infants needing developmental follow-up. This tool aids in early detection of potential developmental delays in vulnerable newborns.
Area of Science:
- Neonatal care
- Pediatric neurology
- Developmental pediatrics
Background:
- High-risk preterm infants require specialized neurodevelopmental follow-up.
- Early identification of developmental delays is crucial for timely intervention.
Purpose of the Study:
- To evaluate the Bayley Infant Neurodevelopmental Screener (BINS) as a tool for neurodevelopmental follow-up in high-risk preterm infants.
- To assess the utility of BINS in identifying infants at risk for developmental delays.
Main Methods:
- A cohort of 122 preterm infants (26-37 weeks gestational age) was studied.
- Medical factors including gestational age, birth weight, and hospitalization details were recorded.
- Neurodevelopmental assessments using BINS were performed at corrected ages, adjusting for prematurity.
Main Results:
- Infants born at 26-29 weeks gestational age (GA) showed significantly lower BINS scores at 7-10 months compared to those born at 30-37 weeks GA.
- Lower scores in expressive and cognitive functions were observed in the earliest preterm group (26-29 weeks GA) at 7-10 months.
- Expressive function scores were significantly lower in the 26-29 weeks GA group at 16-20 months compared to the 33-37 weeks GA group.
Conclusions:
- The Bayley Infant Neurodevelopmental Screener (BINS) demonstrates utility in the neurodevelopmental follow-up of high-risk preterm infants.
- BINS can serve as a rapid screening tool for identifying infants at risk of developmental delays.
- Continued data accumulation will further establish BINS as a valuable instrument in managing neurologically high-risk infants.
Objective:
To examine the utility of the Bayley Infant Neurodevelopmental Screener (BINS) for the neurodevelopmental follow up of high-risk preterms.
Methods:
The study group consisted of 122 preterm infants of the gestational ages between 26 and 37 weeks. Medical factors such as; mean birth weight, gestational age, gender, birth place and type, number of multiple pregnancy, days of hospitalization and oxygen therapy, use of antenatal steroids, and occurrence of sepsis for each patient were evaluated. The neurodevelopmental examination and BINS administration was made at each visit to the patients whose ages were adjusted for prematurity.
Results:
At the corrected age of 7-10 months patients at 26-29 GA had significantly lower total means of BINS scores when compared to those of the other two groups at 30-32 and 33-37 GA (P<0.01 and P<0.001). At the corrected age of 3-4 months, the total means of the BINS scores of the patients at 30-32 GA were lower than that of the patients at 33-37 GA (P<0.009). at 7-10 months the scores of the items defining the expressive and cognitive functions of the patients at 26-29 GA were lower than those of the patients at 30-32 GA (P<0.05) and 33-37 GA (P<0.05). At 16-20 months the mean scores of the items of expressive functions were significantly lower in patients of the 26-29 GA compared to those of the patients of 33-37 GA (P<0.03).
Conclusion:
As data accumulates, BINS will turn out to be a quick way of determining infants at risk of developmental delay in many aspects of neurologically high risk conditions.
